Further work will therefore be required to validate this association and, if confirmed, to characterize the functional mechanisms leading to impaired production of the anti-inflammatory cytokine IL-10 in individuals carrying the IL2–IL21 T1D risk allele. This evidence concerns the gene IL10 and type 1 diabetes mellitus.